chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site pain, Injection site swelling, Vaccination site movement impairment
Clinical narrative: The day after the vaccine I was very wiped out tired; tenderness, redness, and swelling at the injection site; tenderness, redness, and swelling at the injection site; tenderness, redness, and swelling at the injection site; I could barely function; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (I could barely function), FATIGUE (The day after the vaccine I was very wiped out tired), INJECTION SITE PAIN (tenderness, redness, and swelling at the injection site), INJECTION SITE ERYTHEMA (tenderness, redness, and swelling at the injection site) and INJECTION SITE SWELLING (tenderness, redness, and swelling at the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005M21A) for COVID-19 prophylaxis.     Patient didn't received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: Pfizer (1 st dose), Pfizer (first booster dose) and Pfizer (2nd dose). Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer.    On 22-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2022, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (I could barely function). On 23-Apr-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (The day after the vaccine I was very wiped out tired), INJECTION SITE PAIN (tenderness, redness, and swelling at the injection site), INJECTION SITE ERYTHEMA (tenderness, redness, and swelling at the injection site) and INJECTION SITE SWELLING (tenderness, redness, and swelling at the injection site). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (I could barely function), FATIGUE (The day after the vaccine I was very wiped out tired), INJECTION SITE PAIN (tenderness, redness, and swelling at the injection site), INJECTION SITE ERYTHEMA (tenderness, redness, and swelling at the injection site) and INJECTION SITE SWELLING (tenderness, redness, and swelling at the injection site) outcome was unknown.            No concomitant medication was reported. It was reported that the patient had more of a reaction than she did to Pfizer. No treatment information was provided.   This case was linked to MOD-2023-748680, MOD-2023-748686, MOD-2023-748684 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Injection site erythema, Injection site pain, Injection site swelling, Pain
Clinical narrative: swelling at the injection site; Patient felt wiped out the next day but not as bad as the first Moderna Covid-19 vaccine booster dose; Pain; pain at injection site; Redness at the injection site; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Patient felt wiped out the next day but not as bad as the first Moderna Covid-19 vaccine booster dose), PAIN (Pain), INJECTION SITE PAIN (pain at injection site), INJECTION SITE ERYTHEMA (Redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) in a 68-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) (batch no. A17144B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Sep-2022, the patient received fifth dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On 14-Sep-2022, the patient experienced FEELING ABNORMAL (Patient felt wiped out the next day but not as bad as the first Moderna Covid-19 vaccine booster dose), PAIN (Pain), INJECTION SITE PAIN (pain at injection site) and INJECTION SITE ERYTHEMA (Redness at the injection site). On an unknown date, the patient experienced INJECTION SITE SWELLING (swelling at the injection site). At the time of the report, FEELING ABNORMAL (Patient felt wiped out the next day but not as bad as the first Moderna Covid-19 vaccine booster dose), PAIN (Pain), INJECTION SITE PAIN (pain at injection site), INJECTION SITE ERYTHEMA (Redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) outcome was unknown.            No concomitant medication was reported.  No treatment information was reported.   This case was linked to MOD-2023-748680, MOD-2023-748684 (Patient Link).
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Feeling abnormal, Magnetic resonance imaging, Vertigo
Clinical narrative: vertigo; I felt awful; This spontaneous case was reported by a patient and describes the occurrence of VERTIGO (vertigo) and FEELING ABNORMAL (I felt awful) in a 71-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 020H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: JANSSEN COVID-19 VACCINE (had a reaction). Past adverse reactions to the above products included Vaccination adverse reaction with JANSSEN COVID-19 VACCINE.    On 15-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Jan-2023, the patient experienced VERTIGO (vertigo) and FEELING ABNORMAL (I felt awful). The patient was treated with LORAZEPAM (ATIVAN) at an unspecified dose and frequency. At the time of the report, VERTIGO (vertigo) and FEELING ABNORMAL (I felt awful) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: all results showed that her heart, head, were good.         It was unknown if patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concomitant medication not reported.   Right after taking the booster 15 Jan 2023, she felt awful, developed vertigo. She had it every day for 3 months. Just as it came on suddenly, it left suddenly. It was from Jan 2023 until sometime in March 2023. She sought medical attention and was seen by a Neurologist, ENT, and even a Heart doctor. She never associated vertigo with the vaccine until she went to an event in Sept and met 2 people who mentioned during their conversation that they would never get the vaccine because it causes dizziness and vertigo.   This case was linked to MOD-2023-748618 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Feeling abnormal, Swelling, Tenderness
Clinical narrative: arm sight redness; swelling; tenderness; tiredness; hotness/overall crappy feeling; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (arm sight redness), SWELLING (swelling), TENDERNESS (tenderness), FATIGUE (tiredness) and FEELING ABNORMAL (hotness/overall crappy feeling) in a 41-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Nov-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (Intramuscular use) 1 dosage form. In 2023, the patient experienced FEELING ABNORMAL (hotness/overall crappy feeling). On 08-Nov-2023,  after starting mRNA-1273.815 (SPIKEVAX 2023-2024), the patient experienced ERYTHEMA (arm sight redness), SWELLING (swelling), TENDERNESS (tenderness) and FATIGUE (tiredness). At the time of the report, ERYTHEMA (arm sight redness), SWELLING (swelling), TENDERNESS (tenderness) and FATIGUE (tiredness) had not resolved and FEELING ABNORMAL (hotness/overall crappy feeling) outcome was unknown.            Concomitant medication and treatment information were not provided.
Age: 68.0
Sex: M
Vaccine: PNC13
Symptoms: Osteoarthritis
Clinical narrative: have bad knee osteoarthritis; The initial case was missing the following minimum criteria: adverse event. Upon receipt of follow-up information on 30Oct2023, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient. A 76-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), as dose number unknown, single (Batch/Lot number: unknown) at the age of 68 years for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Ppv23 (because it has been more than 5 years), when the patient was 65 years old, for Immunization. The following information was reported: OSTEOARTHRITIS (medically significant), outcome "unknown", described as "have bad knee osteoarthritis". Therapeutic measures were taken as a result of osteoarthritis. Additional information: the patient reported that he has bad knee osteoarthritis, every once in a blue moon he goes and get a cortisone shot directly into the knee. He added that he had PPV23 at 65, PCV13 at 68, because it has been more than 5 years, he may get Prevnar 20.  The information on the batch/lot number for pneumococcal 13-val conj vac (dipht crm197 protein) has been requested and will be submitted if and when received.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: developed shingles/ suspected vaccination failure; developed shingles; This serious case was reported by a consumer and described the occurrence of vaccination failure in a 77-year-old female patient who received Herpes zoster (Shingrix) (batch number 58160082311) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) (batch number 58160082311) for prophylaxis.   On 08-JUL-2020, the patient received the 2nd dose of Shingrix. On 12-FEB-2020, the patient received the 1st dose of Shingrix. On 29-OCT-2023, 1208 days after receiving Shingrix and 1355 days after receiving Shingrix, the patient experienced vaccination failure (Verbatim: developed shingles/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: developed shingles). The patient was treated with valaciclovir (Valacyclovir). The outcome of the vaccination failure was unknown and the outcome of the shingles was not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingrix and Shingrix.   Additional Information: GSK Receipt date: 06-NOV-2023 The reporter was a caregiver. The patient had the Shingrix vial kit. The symptoms were treated. This case was considered as suspected vaccination failure since the details regarding the laboratory confirmation of shingles were unknown at the time of reporting. The reporter consent to follow up.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus
Clinical narrative: Erythema, induration, pruritis several cm at vaccine site
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Decreased appetite, Fatigue, Hypersomnia
Clinical narrative: Event - AM of next day after shot work up feeling weak, chills, no appetite. Excessive tiredness set in. Slept 16 hours. Lasted all day. Sat. 11/4/23, too, drank buttermint tea by Twinings. Rx - slept, took vitamin C500mg chewable. Drank herbal tea, soup broth. Call my doctor. Outcome - felt better on Sun. 11/5/23.
Age: 55.0
Sex: F
Vaccine: FLU4
Symptoms: Blister
Clinical narrative: Blisters on left toes pinky toe and two toes next to it. I could not put the Manufacturer in the blank above. Seqirus, A CSL Company
Sex: F
Vaccine: VARZOS
Symptoms: Dry throat, Lip swelling, Pharyngeal swelling, Sleep disorder
Clinical narrative: I am a 66 year old female and received my first Shigrix vaccine 10/23/2023 at approximately 3:20 pm. Woke up that night around 4:00 am (10/24/2023) and felt a slight swelling in my throat which I was not overly concerned about because I thought I was sleeping with my mouth open, and my throat became dry. HOWEVER, it also felt like my lips were swollen. When I looked at myself in the mirror, I realized that my lips were swollen but I did not really worry about it too much at that point. I stayed up deciding if I did feel worse or needed to go to the hospital it would be smart not t be sleeping. I never felt that I needed medical attention, so I did not go to the hospital that time. It has now been two weeks since I first noticed the swelling in my lips. They are still swollen and it is bothersome. I decided to "search" it and found there are mild side effects of Shingrix which include "mild allergic reaction." The article further states, "These side effects may be temporary, lasting a few days to weeks. However, if the side effects last longer than that, bother you, or become severe, be sure to talk with your doctor or pharmacist. Note: After the Food and Drug Administration (FDA) approves a drug, it tracks side effects of the medication. If you develop a side effect after receiving Shingrix and want to tell the FDA about it, visit". This is how I got to this site and am now filling out this information. The article further states the following can occur in mild side effects: "swelling under your skin, typically in your eyelids, lips, hands, or feet" or "swelling of your mouth, tongue, or throat, which can make it hard to breathe". (Copied from article) I will contact my doctor's office on Monday, November 13, 2023 to find out if there is anything that can be done to relieve the swelling in my lips. I'm very concerned about returning in two to six months to take another dose of the Shingrix vaccine. NOTE: When I was 5 years old, I received the Smallpox vaccine and had a severe allergic reaction to it. (Severe redness that was rapidly spreading outward from the site on the upper part of my left thigh. It pretty well covered my entire thigh and moved across my lower abdomen. I was treated and kept at the hospital until it was cleared up.) I can't help but wonder if that is somehow related to this reaction.
Sex: F
Vaccine: FLUX
Symptoms: Chills, Nausea, Pyrexia, Vomiting, Weight decreased
Clinical narrative: Received flu shot and then developed fever, nausea, chills, and vomiting and weight loss from 11/1-11/7.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Chills, Depression, Fatigue
Clinical narrative: I had Moderna booster vaccine on 11/3/2023. Started having mild fever, chills, nightly sweat, depression, suicidal ideation, anxiety, insomnia, fatigue, night terrors, every day since 11/6/2023 lasting anywhere between 4 to 12 hours per day with bouts of normal period in between. No prior psychiatric history or current infections. No couch or shortness of breath. I've required anti depressants to calm me down every day. I have not had a test for this. Family MDs treating me for symptoms. I have not been able to leave the house since due to excess weakness, and anxiety attacks.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Loss of personal independence in daily activities, Night sweats, Pyrexia, Sleep terror
Clinical narrative: I had Moderna booster vaccine on 11/3/2023. Started having mild fever, chills, nightly sweat, depression, suicidal ideation, anxiety, insomnia, fatigue, night terrors, every day since 11/6/2023 lasting anywhere between 4 to 12 hours per day with bouts of normal period in between. No prior psychiatric history or current infections. No couch or shortness of breath. I've required anti depressants to calm me down every day. I have not had a test for this. Family MDs treating me for symptoms. I have not been able to leave the house since due to excess weakness, and anxiety attacks.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Suicidal ideation
Clinical narrative: I had Moderna booster vaccine on 11/3/2023. Started having mild fever, chills, nightly sweat, depression, suicidal ideation, anxiety, insomnia, fatigue, night terrors, every day since 11/6/2023 lasting anywhere between 4 to 12 hours per day with bouts of normal period in between. No prior psychiatric history or current infections. No couch or shortness of breath. I've required anti depressants to calm me down every day. I have not had a test for this. Family MDs treating me for symptoms. I have not been able to leave the house since due to excess weakness, and anxiety attacks.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Condition aggravated
Clinical narrative: Received updated Pfizer covid vaccine 09/18/2023 and blood pressure increased again. Already on amlodipine 10mg from previous vaccine doses and additional losartan 25mg prescribed.
Age: 2.92
Sex: F
Vaccine: MMRV
Symptoms: Extra dose administered, No adverse event, Wrong product administered
Clinical narrative: No adverse event, person was given an  additional varicella dose.  Varivax and MMRV were given on 11/8/23. Error with MMRV, it was supposed to be MMR. MMR and varicella were supposed to given Seperately, but a Varivax and MMRV were administered. Provider is aware  and will inform patients parent of error.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Hypophagia, Pneumothorax, Pyrexia
Clinical narrative: Patient came from nursing home.  She was diagnosed with COVID-19 couple of weeks ago.  She has been on 2 L oxygen since the onset of COVID-19.  Has cough but has a weak cough and not able to bring up any sputum.  Has low-grade fever today morning. Received antibiotics. Not able to take p.o. well and patient not much improved so it was decided that patient would go on to hospice Is also noted that she had collapse the lower lobe of left lung
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Sputum retention
Clinical narrative: Patient came from nursing home.  She was diagnosed with COVID-19 couple of weeks ago.  She has been on 2 L oxygen since the onset of COVID-19.  Has cough but has a weak cough and not able to bring up any sputum.  Has low-grade fever today morning. Received antibiotics. Not able to take p.o. well and patient not much improved so it was decided that patient would go on to hospice Is also noted that she had collapse the lower lobe of left lung
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, COVID-19, COVID-19 pneumonia, Decreased appetite
Clinical narrative: Came to emergency room with generalized weakness, shortness of breath and poor appetite. Patient was admitted with acute hypoxemic respiratory failure due to COVID-19 pneumonia.  Patient was treated with supplemental oxygen, zinc, vitamin-C, mucolytic, antitussive and empiric antibiotics. Patient also had acute metabolic encephalopathy due to COVID-19 and elevated troponin that was presumed from demand ischemia and type 2 MI. Patient was discharged to skilled nursing facility in a stable medical condition.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Metabolic encephalopathy, Myocardial ischaemia, Troponin increased
Clinical narrative: Came to emergency room with generalized weakness, shortness of breath and poor appetite. Patient was admitted with acute hypoxemic respiratory failure due to COVID-19 pneumonia.  Patient was treated with supplemental oxygen, zinc, vitamin-C, mucolytic, antitussive and empiric antibiotics. Patient also had acute metabolic encephalopathy due to COVID-19 and elevated troponin that was presumed from demand ischemia and type 2 MI. Patient was discharged to skilled nursing facility in a stable medical condition.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Headache, Laboratory test abnormal, Nausea
Clinical narrative: Tested positive for Covid 2/12/22. Presented with N/V, headache, chills, and fevers. Workup in the ER noted sepsis likely due to urinary source and she was admitted for further workup.Treated with antibiotics and dexamethasone.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sepsis, Vomiting
Clinical narrative: Tested positive for Covid 2/12/22. Presented with N/V, headache, chills, and fevers. Workup in the ER noted sepsis likely due to urinary source and she was admitted for further workup.Treated with antibiotics and dexamethasone.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, COVID-19, Cough, Dyspnoea, Emphysema
Clinical narrative: admitted on 10/10/2021 for shortness of breath and cough, chest congestion of 10 days duration.  He tested positive for COVID-19.  CTA chest was done it ruled out a PE but showed significant emphysematous changes.  He was started on IV Decadron.  He was out of window for remdesivir.  He required minimal oxygen initially 2 liters/minute. He was discharged home with new onset home O2.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: admitted on 10/10/2021 for shortness of breath and cough, chest congestion of 10 days duration.  He tested positive for COVID-19.  CTA chest was done it ruled out a PE but showed significant emphysematous changes.  He was started on IV Decadron.  He was out of window for remdesivir.  He required minimal oxygen initially 2 liters/minute. He was discharged home with new onset home O2.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, COVID-19 pneumonia, Hypoxia, Sepsis
Clinical narrative: Patient was admitted to hospital with acute respiratory failure with hypoxia and sepsis due to COVID-19 associated pneumonia.  He was started on IV antibiotics as well as IV steroids.  He was not a candidate for remdesivir secondary to acute renal failure. Discharged to rehab.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Hypotension, Intensive care
Clinical narrative: Patient was diagnosed to have COVID 19 infection, came in with malaise, fever, nausea and vomiting, and was admitted. Developed hypotension and was moved to ICU. Was noted to be in shock, cardiogenic shock was considered however, could be from volume depletion. BP improved and moved out of ICU. Was managed for COVID 19 PNA and acute hypoxic resp failure with steroids, remdesivir and supplemental O2.  Pt is improved and is off O2. Eager to go home. Will DC on prednisone taper
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea, Pyrexia, Shock, Vomiting
Clinical narrative: Patient was diagnosed to have COVID 19 infection, came in with malaise, fever, nausea and vomiting, and was admitted. Developed hypotension and was moved to ICU. Was noted to be in shock, cardiogenic shock was considered however, could be from volume depletion. BP improved and moved out of ICU. Was managed for COVID 19 PNA and acute hypoxic resp failure with steroids, remdesivir and supplemental O2.  Pt is improved and is off O2. Eager to go home. Will DC on prednisone taper
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Brain injury, Cardiac arrest, Diarrhoea, Dyspnoea
Clinical narrative: Presented to hospital with increasing SOB, generalized weakness, diarrhea, upper respiratory symptoms. Received Remdesivir. Suffered cardiac arrest with ROSC. TTM. Anoxic brain injury. Family have decided to transition to hospice care with terminal extubation later today.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory symptom, Therapeutic hypothermia
Clinical narrative: Presented to hospital with increasing SOB, generalized weakness, diarrhea, upper respiratory symptoms. Received Remdesivir. Suffered cardiac arrest with ROSC. TTM. Anoxic brain injury. Family have decided to transition to hospice care with terminal extubation later today.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cough, Death, Diarrhoea
Clinical narrative: Came into the ED with complaint of fever and diarrhea going intermittently for the last 1 week.  She was diagnosed with COVID on 01/12/2021 but denies any shortness of breath or chest pain or dizziness.  COVID-19 pneumonia:  No hypoxia.  Vitamin-C and zinc supplements and monitor clinically.  diagnosed with COVID-19 1/12 and treated with Molnupiravir x 5 days. She improved, but presented and was admitted 1/23 with cough, fever and decrease in urine output. She was treated with medical management and empiric antibiotics. Her condition worsened and she required intubation and initiation of HD on 2/8. HD changed to CRRT 2/9. Patient remained on MVS with improving gas exchange. Her husband related that she did not want prolonged, aggressive care and he and family wanted to respect her wishes. He requested we withdraw life support and place patient on comfort measures today. Patient was extubated and placed on end of life protocol. Patient expired with husband present at 11.05 ho
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Endotracheal intubation, Haemodialysis, Haemofiltration, Pyrexia, Urine output decreased
Clinical narrative: Came into the ED with complaint of fever and diarrhea going intermittently for the last 1 week.  She was diagnosed with COVID on 01/12/2021 but denies any shortness of breath or chest pain or dizziness.  COVID-19 pneumonia:  No hypoxia.  Vitamin-C and zinc supplements and monitor clinically.  diagnosed with COVID-19 1/12 and treated with Molnupiravir x 5 days. She improved, but presented and was admitted 1/23 with cough, fever and decrease in urine output. She was treated with medical management and empiric antibiotics. Her condition worsened and she required intubation and initiation of HD on 2/8. HD changed to CRRT 2/9. Patient remained on MVS with improving gas exchange. Her husband related that she did not want prolonged, aggressive care and he and family wanted to respect her wishes. He requested we withdraw life support and place patient on comfort measures today. Patient was extubated and placed on end of life protocol. Patient expired with husband present at 11.05 ho
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, COVID-19 pneumonia, Constipation, Myalgia, Nausea
Clinical narrative: Presented with myalgias, fever, nausea, abdominal pain and constipation. Diagnosed with pneumonia due to Covid 19. Remained on room air throughout hospitalization. She was treated with antibiotics and steroids.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Presented with myalgias, fever, nausea, abdominal pain and constipation. Diagnosed with pneumonia due to Covid 19. Remained on room air throughout hospitalization. She was treated with antibiotics and steroids.
Age: 19.0
Sex: F
Vaccine: FLUC4
Symptoms: Blood pressure decreased, Confusional state, Dizziness, Hyperhidrosis, Tremor
Clinical narrative: Starting around 15:00 Patient had an event following within 5 minutes of administration of the influenza vaccination. She endorses feeling dizzy followed by shaking and a brief period of unresponsiveness. Her heart rate was regular and a rate between 50-60. Her BP fell from 115/70 to 80/60. She developed diaphoresis. She become responsive but acted confused for around 1-2 minutes. She returned to baseline by 15:15 ***
Age: 19.0
Sex: F
Vaccine: FLUC4
Symptoms: Unresponsive to stimuli
Clinical narrative: Starting around 15:00 Patient had an event following within 5 minutes of administration of the influenza vaccination. She endorses feeling dizzy followed by shaking and a brief period of unresponsiveness. Her heart rate was regular and a rate between 50-60. Her BP fell from 115/70 to 80/60. She developed diaphoresis. She become responsive but acted confused for around 1-2 minutes. She returned to baseline by 15:15 ***
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea, Fatigue
Clinical narrative: Presented to the hospital for worsening SOB and fatigue, intermittent fever. Diagnosed with acute COPD  exacerbation due to covid pneumonia. Treated with steroids and bronchidilators. Also received Remdesivir.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Presented to the hospital for worsening SOB and fatigue, intermittent fever. Diagnosed with acute COPD  exacerbation due to covid pneumonia. Treated with steroids and bronchidilators. Also received Remdesivir.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Cough, Fatigue, Inflammatory marker test
Clinical narrative: Acute hypoxic respiratory failure due to COVID-19 pneumonia:  Completed course of Remdisivir. Symptoms also include nonproductive cough, wheezing, fatigue, vomiting. Received Actemra on 01/28/2022.  empiric antibiotics, IV steroids, nebs, oxygen.  On Lovenox for DVT prophylaxis, will switch to apixaban as outpt for 2 weeks.  Monitoring COVID-19 inflammatory markers. Completed steroids
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting, Wheezing
Clinical narrative: Acute hypoxic respiratory failure due to COVID-19 pneumonia:  Completed course of Remdisivir. Symptoms also include nonproductive cough, wheezing, fatigue, vomiting. Received Actemra on 01/28/2022.  empiric antibiotics, IV steroids, nebs, oxygen.  On Lovenox for DVT prophylaxis, will switch to apixaban as outpt for 2 weeks.  Monitoring COVID-19 inflammatory markers. Completed steroids
Age: 70.0
Sex: F
Vaccine: RSV
Symptoms: Abdominal discomfort, Abdominal distension, Abdominal pain, Hyperchlorhydria, Mobility decreased
Clinical narrative: Started as acid stomach and bloating. Bloating continues till I felt I had obstructions in my colon.  Sever Abdominal pain that was felt under my right side and rib cage. So painful I could barely walk or move.
Age: 70.0
Sex: F
Vaccine: RSV
Symptoms: Musculoskeletal chest pain
Clinical narrative: Started as acid stomach and bloating. Bloating continues till I felt I had obstructions in my colon.  Sever Abdominal pain that was felt under my right side and rib cage. So painful I could barely walk or move.
Age: 85.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Blindness unilateral, Dizziness, Fatigue, Gait disturbance
Clinical narrative: Patient says that she lost vision in her left eye about 45 minutes to an hour after receiving her vaccinations. She was aslo extremely fatigued and went to lay down. She woke up the next morning, told a friend about the incident but did not seek any medical intervention.  She also told her friend she felt a little dizzy, was swaying , and staggering when she woke up but that resolved itself as the day progressed. Her vision loss had also resolved  itself the next morning.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Mechanical urticaria, Urticaria, Vaccine positive rechallenge
Clinical narrative: Intermittent hives, mild dermatographism managed with cetirizine  At time adverse event occured, patient ~ 8 weeks pregnant, estimated date of delivery May 2024
Age: 82.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site reaction, Rash
Clinical narrative: Patient returned to office on 11/13/2023. Patient reported painful rash on left upper arm at injection site. Patient reports symptoms began on 11/09/2023, 2 days after injection administration, and that they have been worsening since then.  Physician  examined patient and advised on treatment.  Treatment plan was advised for pat to take Benadryl and use Ice for rash. A steroid pack was offered and declined at this time. Pt was advised to call office if symptoms are not improving.
Age: 27.0
Sex: F
Vaccine: FLU4
Symptoms: Biopsy skin, Rash, Urticaria
Clinical narrative: Employee developed an Urticarial rash involving, right side of abdomen, extending to the right flank. both upper arms, and posterior knees, and thighs.
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19
Clinical narrative: hospitalized with COVID
Age: 41.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Erythema, Mass, Pruritus
Clinical narrative: Thursday 11/9  around 3pm noticed red bumps all over my arms, torso, legs back, and chest - non itchy at this time.  Called my PCP, got an appointment for Friday 11/10 at 3:30pm, by this time the bumps were starting to itchy slightly.  The bumps had multiplied and gotten bigger and redder.  Was prescribed Prednisone 10 mg - 4 pills for 5 days, 3 pills for 3 days, 2 pills for 3 days
Age: 93.0
Sex: F
Vaccine: UNK
Symptoms: Dizziness, Headache
Clinical narrative: Dizziness and a dull headache, I had a temperature of 99 when the ambulance got here. I called EMS because I was dizzy and the papers say to call EMS if I experience dizziness. They checked me out and said I didn't need to go to the ER.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Joint swelling, Muscle spasms, Urticaria
Clinical narrative: Client called to report she developed welts over her legs and torso within the first day after vaccination and she continues to have charley horses in the back of her legs and a swollen knee. She did not have blood clots but is going to see a neurologist for follow up.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Inflammatory marker test, Joint lock, Joint stiffness, Muscle spasms, Muscular weakness
Clinical narrative: Client called to report she developed welts over her legs and torso within the first day after vaccination and she continues to have charley horses in the back of her legs and a swollen knee. She did not have blood clots but is going to see a neurologist for follow up.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Ultrasound Doppler, Urticaria
Clinical narrative: Client called to report she developed welts over her legs and torso within the first day after vaccination and she continues to have charley horses in the back of her legs and a swollen knee. She did not have blood clots but is going to see a neurologist for follow up.
Age: 0.33
Sex: M
Vaccine: DTAPIPV
Symptoms: Infant irritability, Injection site swelling, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Patient received incorrect administration of Kinrix vaccine (not within age range to receive) instead of age appropriate IPV and DTaP.   At the time of vaccination, patient was teething and had an ear infection. Patient had a bump on his arm where the vaccines were received and seemed more irritable.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalized with COVID
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Unresponsive to stimuli
Clinical narrative: Per pt family member, patient was found unresponsive in home on 11-9-23. Patient was rushed to local hospital where he passed away later that same afternoon.  Cause of death unknown at this time.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray abnormal, Electrocardiogram normal, Gastrointestinal haemorrhage
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/1/2023 Discharge Date: 9/4/23 Discharge Disposition:  skilled nursing facility      Active Issues Requiring Follow-up:  Deconditioning: SAR on discharge  ?  No future appointments.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Pt is a 84 yr old F with PMHx of recent GI bleed at Facility in July 2023, HTN, HLD, GERD, spinal stenosis, chronic back pain, OAB, urinary retention, Parkinson's disease, depression and insomnia presented to ED on 9/1 with weakness from Independent living. She was ambulating and felt her legs were weak so she lowered herself to the ground without any injuries, fall or trauma.    In the ER- pt was hypertensive but otherwise stable. Labs without acute pathology. COVID positive, EKG NSR without acute ischemic changes. CXR with patchy airspace disease.  No medications given in the ER.    Pt admitted for Remdesivir and PT/OT eval. As patient was not hypoxic, steroid were not started.   PT/OT recommended SAR on discharge to help with deconditioning and to improve overall strength. She was discharged to SAR in stable conditions on RA with covid precautions and plans to follow up with PCP after SAR.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Laboratory test abnormal, Lung disorder, Muscular weakness, Physical deconditioning
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/1/2023 Discharge Date: 9/4/23 Discharge Disposition:  skilled nursing facility      Active Issues Requiring Follow-up:  Deconditioning: SAR on discharge  ?  No future appointments.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Pt is a 84 yr old F with PMHx of recent GI bleed at Facility in July 2023, HTN, HLD, GERD, spinal stenosis, chronic back pain, OAB, urinary retention, Parkinson's disease, depression and insomnia presented to ED on 9/1 with weakness from Independent living. She was ambulating and felt her legs were weak so she lowered herself to the ground without any injuries, fall or trauma.    In the ER- pt was hypertensive but otherwise stable. Labs without acute pathology. COVID positive, EKG NSR without acute ischemic changes. CXR with patchy airspace disease.  No medications given in the ER.    Pt admitted for Remdesivir and PT/OT eval. As patient was not hypoxic, steroid were not started.   PT/OT recommended SAR on discharge to help with deconditioning and to improve overall strength. She was discharged to SAR in stable conditions on RA with covid precautions and plans to follow up with PCP after SAR.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus rhythm
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/1/2023 Discharge Date: 9/4/23 Discharge Disposition:  skilled nursing facility      Active Issues Requiring Follow-up:  Deconditioning: SAR on discharge  ?  No future appointments.   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Pt is a 84 yr old F with PMHx of recent GI bleed at Facility in July 2023, HTN, HLD, GERD, spinal stenosis, chronic back pain, OAB, urinary retention, Parkinson's disease, depression and insomnia presented to ED on 9/1 with weakness from Independent living. She was ambulating and felt her legs were weak so she lowered herself to the ground without any injuries, fall or trauma.    In the ER- pt was hypertensive but otherwise stable. Labs without acute pathology. COVID positive, EKG NSR without acute ischemic changes. CXR with patchy airspace disease.  No medications given in the ER.    Pt admitted for Remdesivir and PT/OT eval. As patient was not hypoxic, steroid were not started.   PT/OT recommended SAR on discharge to help with deconditioning and to improve overall strength. She was discharged to SAR in stable conditions on RA with covid precautions and plans to follow up with PCP after SAR.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Acute respiratory failure, Arthralgia, Dyspnoea, Headache, Malaise
Clinical narrative: Received phone call from patient  on 11/13/23 regarding vaccine adverse reactions that started on 10/30/23. Patient stated receiving the 2nd dose of  Shingles vaccine that day in the morning. She had a history of Asthma. It wasn't until later that evening that she experienced severe difficulty breathing and joint pain. None of her inhalers were improving her symptoms. Patient called EMS and was transported to the hospital.  Patient was hospitalized on 11/4/23 through 11/7/23 for Acute Respiratory Failure.  Patient did not have these reactions after the first Shingles vaccine. She stated that she had a headache and was not feeling well for 2 to 3 days. Symptoms improved after first Shingles vaccine.
Age: 1.17
Sex: M
Vaccine: FLU4, HEP
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: patient was not due for Hep B, was given Hep B in error, No adverse reaction reported by mom
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Back pain, COVID-19, Chest X-ray abnormal, Cough
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/1/2023 Discharge Date: 9/12/2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1] COVID-19 with multiple comorbidities [U07.1]   HOSPITAL COURSE: 80M with HTN Hypothyroid chronic back pain, wheelchair bound at baseline, post polio syndrome. He resides at LTCF. He reported increased weakness, tiredness,  and dry cough. No fever nor diarrhea   He presented to emergency department workup revealed that he is  COVID positive. CXR showed prominent vascular hila and interstitial markings. He completed 5 days of remdesivir. IV lasix given to facilitate a negative fluid balance. Echo with EF of 55% LVSF nromal no pericardial effusion   Patient did well. His cough improved. He was out of COVID isolation 9/12. He remained asymptomatic while waiting isolation completion. He was discharged on 9/12/2023 back to his living facility in stable condition. It is recommended that patient follow up with his PCP as an outpatient.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Echocardiogram normal, Ejection fraction normal, Fatigue, Hypertension, Hypothyroidism
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/1/2023 Discharge Date: 9/12/2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1] COVID-19 with multiple comorbidities [U07.1]   HOSPITAL COURSE: 80M with HTN Hypothyroid chronic back pain, wheelchair bound at baseline, post polio syndrome. He resides at LTCF. He reported increased weakness, tiredness,  and dry cough. No fever nor diarrhea   He presented to emergency department workup revealed that he is  COVID positive. CXR showed prominent vascular hila and interstitial markings. He completed 5 days of remdesivir. IV lasix given to facilitate a negative fluid balance. Echo with EF of 55% LVSF nromal no pericardial effusion   Patient did well. His cough improved. He was out of COVID isolation 9/12. He remained asymptomatic while waiting isolation completion. He was discharged on 9/12/2023 back to his living facility in stable condition. It is recommended that patient follow up with his PCP as an outpatient.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Interstitial lung disease, Multimorbidity, Pulmonary hilar enlargement, SARS-CoV-2 test positive
Clinical narrative: BRIEF OVERVIEW: Admission Date: 9/1/2023 Discharge Date: 9/12/2023 Discharge Disposition:  home or self care  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness [R53.1] COVID-19 [U07.1] COVID-19 with multiple comorbidities [U07.1]   HOSPITAL COURSE: 80M with HTN Hypothyroid chronic back pain, wheelchair bound at baseline, post polio syndrome. He resides at LTCF. He reported increased weakness, tiredness,  and dry cough. No fever nor diarrhea   He presented to emergency department workup revealed that he is  COVID positive. CXR showed prominent vascular hila and interstitial markings. He completed 5 days of remdesivir. IV lasix given to facilitate a negative fluid balance. Echo with EF of 55% LVSF nromal no pericardial effusion   Patient did well. His cough improved. He was out of COVID isolation 9/12. He remained asymptomatic while waiting isolation completion. He was discharged on 9/12/2023 back to his living facility in stable condition. It is recommended that patient follow up with his PCP as an outpatient.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalized with covid
Age: 86.0
Sex: F
Vaccine: RSV
Symptoms: Injection site erythema, Injection site induration, Injection site mass, Injection site pain, Injection site warmth
Clinical narrative: Developed a hard lump on left arm 1" below the injection site.  Lump is 4" x 4.5 " long.  Red, warm and painful.  Patient is applying cold packs and taking Tylenol.
Age: 30.0
Sex: F
Vaccine: FLU4
Symptoms: Injected limb mobility decreased, Pain
Clinical narrative: Right shoulder with decreased motion after receiving flu shot. History of chronic shoulder pain and history of steroid injections in the past. Pain with flexion and abduction
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Gait disturbance, Headache, Tremor
Clinical narrative: Patient received her COVID vaccination in our pharmacy department at about 1:00 PM on Friday 11/10/23.  She has a history of feeling dizzy/lightheaded after vaccinations, so she premedicated with 1 tablet of Metoprolol succinate 50mg about 1 hour before her vaccination.  We had her sit in our waiting area for the required 15 minutes, and by about 1:05 PM patient reported feeling "spacey".  She also felt lightheaded, dizzy, and developed a shaking in her arms.  She was not able to stand up on her own, she did not feel stable enough.  EMS was called for the patient at that time, around 1:05 PM.  An EMT arrived on the scene at about 1:10PM.  Immediately her BP, pulse, and heart rhythm were checked.  All were normal according to the EMT.  She also mentioned to the EMT around 1:11 PM that see felt she was developing a headached.  Patient was taken to Hospital for observation as her reaction was not what the EMT would expect as an allergic reaction to the vaccine.  Upon checking with the patient's mother around 3 PM, patient was given a dose of Ativan at the hospital and was feeling better.  She was discharged later in the evening.  Spoke with patient again around 5/6 PM, and she was feeling much better.
Age: 45.0
Sex: F
Vaccine: FLU4
Symptoms: Burning sensation, CSF myelin basic protein abnormal, CSF oligoclonal band absent, Defaecation urgency, Gait disturbance
Clinical narrative: Four days after vaccine was given, patient experienced arm heaviness, gait instability, right hand numbness, and leg nubness from hip to feet. Patient presented to local hospital ER where provider evaluated and determined nothing was wrong. The condition got worse, legs began to shake, patient then presented to a larger hospital ER for a neurological evaluation. Patient was admitted to the hospital and worked up for stroke symptoms as well as trans-ischmic attack, which were negative. Numbness persisted and MRI with contrast of brain and cervical spine was done. It was noted that there were 3 lesions in the cervical spine area that were likely the cause of the patients symptoms. A spinal tap was deferred until wash out period of antiplatelet therapy was done. Patient received 3 x 1gm Methylprednisolone in the hosptial and was discharged on day 4 after presetation to hospital with diagnosis of acute transverse myelitis. Patient received spinal tap 7 days later with additonial blood testing. Significant findings from spinal tap included myelin binding protein and was negative for oligioclonal bands. No infection was noted. Patient followed up with neurologist on day 29 of symptom onset after discharge. Patient continues to have symptoms of numbness and burnign in legs and feet, numbness in torso region and right hand fingertips. She has bowel and bladder urgency but not incontinence. The neurologist determined this was an isolated case of acute transverse myelitis as all other potential neruological conditions were ruled out. Further MRI of brain and cervical spine recommended in 5 months to determine resolution of leisons or worsening of condition. Patient received a second course of oral prednisone taper for ongoing symptoms.